Primary Site >> Colorectal Cancer
Gene >> ANXA3
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: Proteomics-based validation of genomic data: applications in colorectal cancer diagnosis. PMID: 16733264 |
Ref: A blood-based biomarker panel for stratifying current risk for colorectal cancer. PMID: 19795455 Ref: A case-controlled validation study of a blood-based seven-gene biomarker panel for colorectal cancer in Malaysia. PMID: 20846378 Ref: Identification of distinctive protein expression patterns in colorectal adenoma. PMID: 21137016 |
Ref: Proteomic analysis identifies translationally controlled tumor protein as a mediator of phosphatase of regenerating liver-3-promoted proliferation, migration and invasion in human colon cancer cells. PMID: 22340241 |
Ref: Prognostic value of Annexin A3 in human colorectal cancer and its correlation with hypoxia-inducible factor-1alpha PMID: 24260057 |
Ref: Verification of gene expression profiles for colorectal cancer using 12 internet public microarray datasets. PMID: 25516661 |
Ref: High-throughput proteomics integrated with gene microarray for discovery of colorectal cancer potential biomarkers. PMID: 27661117 |
Ref: The MiR-495/Annexin A3/P53 Axis Inhibits the Invasion and EMT of Colorectal Cancer Cells. PMID: 29224019 |
Ref: Proteomic profiling of antibody-inducing immunogens in tumor tissue identifies PSMA1, LAP3, ANXA3, and maspin as colon cancer markers. PMID: 29423100 Ref: MiR-340-5p is a potential prognostic indicator of colorectal cancer and modulates ANXA3. PMID: 30070320 Ref: MiR-340-5p is a potential prognostic indicator of colorectal cancer and modulates ANXA3. It is a cost-effective genetic test. PMID: 30280753 |